(NP (NP (NN Enhancement)) (PP (IN of) (NP (NP (JJ human) (NN immunodeficiency) (NN virus) (CD 1) (NN replication)) (PP (IN in) (NP (NNS monocytes))))) (PP (IN by) (NP (NN 1,25-dihydroxycholecalciferol))) (. .))
(S (NP-SBJ (NP (NP (JJ Human) (NN immunodeficiency) (NN virus)) (PRN (-LRB- -LRB-) (NP (NN HIV)) (-RRB- -RRB-))) (NP-COOD (NP (NN expression)) (CC and) (NP (NN replication)))) (VP (VBP are) (PP-PRD (IN under) (NP (JJ tight) (JJ regulatory) (NN control)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (NN 1,25-dihydroxycholecalciferol)) (PRN (-LRB- -LCB-) (NP (NN 1,25--LRB-OH-RRB-2D3)) (-RRB- -RCB-))) (VP (VBZ enhances) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (NP (ADJP-COOD (ADJP (NP (NN monocyte-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ lymphocyte-tropic))) (NNS strains)) (PP (IN of) (NP (NN HIV-1)))))) (PP (IN up) (TO to) (ADVP (RB 10,000-fold))) (PP (IN in) (NP-COOD (NP (NN monocyte) (NN cell) (NNS lines)) (, ,) (NP (JJ peripheral) (NN blood) (NNS monocytes)) (, ,) (CC and) (NP (JJ unfractionated) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells)))))))) (. .))
(S (NP-SBJ (NN 1,25-LRB-OH-RRB-2D3)) (VP (VBZ is) (ADVP (RB therefore)) (NP-PRD (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ potent)) (NNS regulators)) (PP (IN of) (NP (NN HIV-1) (NN replication))) (VP (VBN described) (NP (-NONE- *)) (PP-TMP (TO to) (NP (NN date)))))))) (. .))
(S (NP-SBJ (NP (NNS Precursors)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3)))) (VP (VBP enhance) (NP (NN HIV-1) (NN replication)) (PP (IN in) (NN proportion) (TO to) (NP (NP (PRP$ their) (NN affinity)) (PP (IN for) (NP (DT the) (NN 1,25-LRB-OH-RRB-2D3) (JJ intracellular) (NN receptor))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN 1,25-LRB-OH-RRB-2D3)) (VP (VBZ influences) (NP (NN HIV-1) (NN replication)) (PP (IN by) (NP (NP (NNS mechanisms)) (VP (VBG involving) (NP (DT this) (NN receptor))))))))))) (. .))
(S (NP-SBJ (DT These) (NNS studies)) (VP (MD may) (VP (VB have) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NP (DT the) (NN design)) (PP (IN of) (NP (NP (JJ effective) (NN therapy)) (PP (IN of) (NP (NN HIV-1) (NN infection)))))))))) (. .))
